Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 415 followers
Latest posts
Last updated about 14 hours ago
FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
about 14 hours ago
Following dynamite data that earned a standing ovation at the American Society...
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
about 14 hours ago
Fresh off a phase 3 win in biliary tract cancer, Akeso CEO...
Baxter issues recall of 2 products after particulate concerns resurface
about 15 hours ago
Baxter has initiated a recall of two products because of particulate matter...
With Trump's nominee pick in, FDA weighs new deputy commissioner posts: report
about 16 hours ago
As the leadership vacuum at the top of the FDA looks poised...
Teva faces fresh antitrust scrutiny, this time via competition probe in Turkey
about 17 hours ago
Teva is increasingly highlighting its innovative drug bona fides these days, seeking...
NAD reaches split decision on hair ad row between Kenvue and Hims & Hers
1 day ago
The National Advertising Division has delivered a mixed verdict in a row...
McKesson strikes $2.25B deal to snap up Precision Medicine Group
1 day ago
The healthcare conglomerate ,which ranks eighth on the Fortune 500 list, is...
Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3
1 day ago
Bausch + Lomb has come up short in a phase 2 trial...
Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancer
1 day ago
Jazz’s bispecific antibody Ziihera has gained an FDA approval for first-line HER2-positive...
Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'
1 day ago
The “knowledge base is going to start shifting quickly to China,” Rep...
Johnson & Johnson scores 1st FDA label expansion for Imaavy
1 day ago
Sixteen months after Johnson & Johnson scored its initial FDA approval for...
Lundbeck strikes expanded pact with Eversana to broaden AI scope across US commercial business
1 day ago
The partnership builds on previous work and will expand Lundbeck's use of...